|

Precision Medicine for L/GCMN and Melanoma 2

RECRUITINGSponsored by Fundacion Clinic per a la Recerca Biomédica
Actively Recruiting
SponsorFundacion Clinic per a la Recerca Biomédica
Started2025-01-01
Est. completion2026-09-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06605443

Summary

The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Be over 18 years old
* Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC)

Exclusion Criteria:

* Not signing the informed consent form
* Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile organic compound profiles

Conditions4

CancerCongenital Melanocytic NevusMelanoma (Skin Cancer)Nevi and Melanomas

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.